Literature DB >> 31232854

Trauma Bay Disposition of Infants and Young Children With Mild Traumatic Brain Injury and Positive Head Imaging.

Corina Noje1, Eric M Jackson2, Isam W Nasr3, Philomena M Costabile4, Marcelo Cerullo5, Katherine Hoops1, Lindsey Rasmussen6, Eric Henderson7, Susan Ziegfeld3, Lisa Puett3,4, Courtney L Robertson1.   

Abstract

OBJECTIVES: To describe the disposition of infants and young children with isolated mild traumatic brain injury and neuroimaging findings evaluated at a level 1 pediatric trauma center, and identify factors associated with their need for ICU admission.
DESIGN: Retrospective cohort.
SETTING: Single center. PATIENTS: Children less than or equal to 4 years old with mild traumatic brain injury (Glasgow Coma Scale 13-15) and neuroimaging findings evaluated between January 1, 2013, and December 31, 2015. Polytrauma victims and patients requiring intubation or vasoactive infusions preadmission were excluded.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Two-hundred ten children (median age/weight/Glasgow Coma Scale: 6 mo/7.5 kg/15) met inclusion criteria. Most neuroimaging showed skull fractures with extra-axial hemorrhage/no midline shift (30%), nondisplaced skull fractures (28%), and intracranial hemorrhage without fractures/midline shift (19%). Trauma bay disposition included ICU (48%), ward (38%), intermediate care unit and home (7% each). Overall, 1% required intubation, 4.3% seizure management, and 4.3% neurosurgical procedures; 15% were diagnosed with nonaccidental trauma. None of the ward/intermediate care unit patients were transferred to ICU. Median ICU/hospital length of stay was 2 days. Most patients (99%) were discharged home without neurologic deficits. The ICU subgroup included all patients with midline shift, 62% patients with intracranial hemorrhage, and 20% patients with skull fractures. Across these imaging subtypes, the only clinical predictor of ICU admission was trauma bay Glasgow Coma Scale less than 15 (p = 0.018 for intracranial hemorrhage; p < 0.001 for skull fractures). A minority of ICU patients (18/100) required neurocritical care and/or neurosurgical interventions; risk factors included neurologic deficit, loss of consciousness/seizures, and extra-axial hemorrhage (especially epidural hematoma).
CONCLUSIONS: Nearly half of our cohort was briefly monitored in the ICU (with disposition mostly explained by trauma bay imaging, rather than clinical findings); however, less than 10% required ICU-specific interventions. Although ICU could be used for close neuromonitoring to prevent further neurologic injury, additional research should explore if less conservative approaches may preserve patient safety while optimizing healthcare resource utilization.

Entities:  

Year:  2019        PMID: 31232854      PMCID: PMC7050196          DOI: 10.1097/PCC.0000000000002033

Source DB:  PubMed          Journal:  Pediatr Crit Care Med        ISSN: 1529-7535            Impact factor:   3.624


  21 in total

1.  ED disposition of the Glasgow Coma Scale 13 to 15 traumatic brain injury patient: analysis of the Transforming Research and Clinical Knowledge in TBI study.

Authors:  Jonathan J Ratcliff; Opeolu Adeoye; Christopher J Lindsell; Kimberly W Hart; Arthur Pancioli; Jason T McMullan; John K Yue; Daniel K Nishijima; Wayne A Gordon; Alex B Valadka; David O Okonkwo; Hester F Lingsma; Andrew I R Maas; Geoffrey T Manley
Journal:  Am J Emerg Med       Date:  2014-04-13       Impact factor: 2.469

2.  Acute outcomes of isolated cerebral contusions in children with Glasgow Coma Scale scores of 14 to 15 after blunt head trauma.

Authors:  Paul Varano; Keven I Cabrera; Nathan Kuppermann; Peter S Dayan
Journal:  J Trauma Acute Care Surg       Date:  2015-05       Impact factor: 3.313

3.  Development and Internal Validation of a Clinical Risk Score for Treating Children With Mild Head Trauma and Intracranial Injury.

Authors:  Jacob K Greenberg; Yan Yan; Christopher R Carpenter; Angela Lumba-Brown; Martin S Keller; Jose A Pineda; Ross C Brownson; David D Limbrick
Journal:  JAMA Pediatr       Date:  2017-04-01       Impact factor: 16.193

4.  How fast will the registered nurse workforce grow through 2030? Projections in nine regions of the country.

Authors:  David I Auerbach; Peter I Buerhaus; Douglas O Staiger
Journal:  Nurs Outlook       Date:  2016-07-13       Impact factor: 3.250

5.  Critical Care Resource Utilization and Outcomes of Children With Moderate Traumatic Brain Injury.

Authors:  Theerada Chandee; Vivian H Lyons; Monica S Vavilala; Vijay Krishnamoorthy; Nophanan Chaikittisilpa; Arraya Watanitanon; Abhijit V Lele
Journal:  Pediatr Crit Care Med       Date:  2017-12       Impact factor: 3.624

6.  The Injury Severity Score revisited.

Authors:  W S Copes; H R Champion; W J Sacco; M M Lawnick; S L Keast; L W Bain
Journal:  J Trauma       Date:  1988-01

7.  Traumatic stress in parents of children admitted to the pediatric intensive care unit.

Authors:  Andrew Balluffi; Nancy Kassam-Adams; Anne Kazak; Michelle Tucker; Troy Dominguez; Mark Helfaer
Journal:  Pediatr Crit Care Med       Date:  2004-11       Impact factor: 3.624

8.  Pediatric sports-related traumatic brain injury in United States trauma centers.

Authors:  John K Yue; Ethan A Winkler; John F Burke; Andrew K Chan; Sanjay S Dhall; Mitchel S Berger; Geoffrey T Manley; Phiroz E Tarapore
Journal:  Neurosurg Focus       Date:  2016-04       Impact factor: 4.047

Review 9.  Controversies in the evaluation and management of minor blunt head trauma in children.

Authors:  David Schnadower; Hector Vazquez; June Lee; Peter Dayan; Cindy Ganis Roskind
Journal:  Curr Opin Pediatr       Date:  2007-06       Impact factor: 2.856

10.  The use of repeated head computed tomography in pediatric blunt head trauma: factors predicting new and worsening brain injury.

Authors:  William Hollingworth; Monica S Vavilala; Jeffrey G Jarvik; Sidhartha Chaudhry; Brian D Johnston; Sarah Layman; Nuj Tontisirin; Saipin L Muangman; Marjorie C Wang
Journal:  Pediatr Crit Care Med       Date:  2007-07       Impact factor: 3.624

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.